Skip to Main Content

Paper Details

A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer.
Clin Genitourin Cancer
2
2021
Author NameAffiliation
Scott T Tagawa
Dana E RathkopfMemorial Sloan Kettering Cancer Center
Neeta Pandit-TaskarMemorial Sloan Kettering Cancer Center
Michael J MorrisMemorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2